Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
0 this month

Showing 10161–10180 of 17,529 recalls

May 5, 2017· Ascend Laboratories LLC

Recalled Item: AMLODIPINE BESYLATE TABLET

The Issue: PRESENCE OF FOREIGN TABLETS/CAPSULES: A 2.5 mg Amlodipine

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
May 5, 2017· Genetic Edge Compounds LLC

Recalled Item: GEC LX Laxoplex 60 capsules Dietary Supplement

The Issue: Undeclared Anabolic

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
May 2, 2017· Lupin Pharmaceuticals Inc.

Recalled Item: Famotidine for Oral Suspension USP

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
May 1, 2017· Allergan Sales, LLC

Recalled Item: Blephamide (sulfacetamide sodium and prednisolone acetate ophthalmic ointment

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 28, 2017· PAR Sterile Products LLC

Recalled Item: Buprenorphine HCI Injection

The Issue: Crystallization: due to the presence of white, crystalline

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 27, 2017· Noven Pharmaceuticals, Inc.

Recalled Item: Minivelle (estradiol Transdermal System) 0.1 mg per day

The Issue: Defective Delivery System: Out of specification for peel

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
April 27, 2017· Hetero USA Inc

Recalled Item: Acyclovir Tablets

The Issue: Presence of Foreign Substance: human hair melded into

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
April 26, 2017· Sandoz Inc

Recalled Item: Amoxicillin and Clavulanate Potassium Tablets

The Issue: Subpotent Drug; Clavulanic Acid

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
April 24, 2017· Teva Pharmaceuticals USA

Recalled Item: Clozapine Tablets USP

The Issue: Microbial Contamination of Non-Sterile Products

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 21, 2017· Hospira Inc.

Recalled Item: Infant 25% DEXTROSE Injection

The Issue: Presence of Particulate Matter: human hair found within

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
April 20, 2017· C. O. Truxton

Recalled Item: Phenobarbital Tablets USP

The Issue: Mislabeling

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
April 20, 2017· C. O. Truxton

Recalled Item: Amitriptyline HCL Tablets

The Issue: Mislabeling

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 20, 2017· C. O. Truxton

Recalled Item: Phenobarbital Tablets USP

The Issue: Labeling: Labeled Error on Declared Strength; report of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
April 20, 2017· C. O. Truxton

Recalled Item: Phenobarbital Tablets USP

The Issue: Mislabeling

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 20, 2017· C. O. Truxton

Recalled Item: Phenobarbital Tablets USP

The Issue: Mislabeling

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 20, 2017· C. O. Truxton

Recalled Item: Phenobarbital Tablets USP

The Issue: Mislabeling

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 20, 2017· Akorn, Inc.

Recalled Item: IC-Green (indocyanine green for injection

The Issue: Product is being recalled due to low pH

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
April 19, 2017· Gentell, Inc

Recalled Item: Shield and Protect Moisture Barrier Cream

The Issue: GMP Deviations; product may not meet cGMP requirements

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 19, 2017· Qualgen

Recalled Item: Estradiol 20 mg pellet 99.5% Estradiol USP

The Issue: CGMP deviations- Lack of Quality Assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 19, 2017· Qualgen

Recalled Item: Estradiol 12.5 mg pellet 99.5% Estradiol USP

The Issue: CGMP deviations- Lack of Quality Assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund